DAMONA raises US5.5 Million Seed Stage Financing to Advance Lead Molecule Development to Treat Cognitive Deficits
read moreAltered GABA-mediated information processing and cognitive dysfunctions in depression and other brain disorders
Altered GABA-mediated information processing and cognitive dysfunctions in depression and other brain disorders https://www.damonapharma.com/wp-content/uploads/2020/04/article-image4.png 1920 800 Etienne Sibille https://secure.gravatar.com/avatar/31fca8d52a9ddc2456d689e55abc91df?s=96&d=mm&r=gCognitive dysfunctions, including impaired attention, learning, memory, planning and problem solving, occur in depressive episodes, often persist during remission, predict relapse, worsen with recurrent episodes, and are not treated by current antidepressants or other medications.
CAMH Engage Breakthrough Challenge 2019 awarded to Dr. Thomas Prevot
CAMH Engage Breakthrough Challenge 2019 awarded to Dr. Thomas Prevot https://www.damonapharma.com/wp-content/uploads/2019/10/BTC-Picture-Thomas.png 1440 780 Etienne Sibille https://secure.gravatar.com/avatar/31fca8d52a9ddc2456d689e55abc91df?s=96&d=mm&r=gOn October the 18th, a sold-out crowd of nearly 300 young professionals gathered at Ricarda’s Toronto to award $10,000 as part of the 6th Annual Breakthrough Challenge, a signature event by CAMH Engage in support of mental health research. CAMH Engage is a group of young professionals in Toronto dedicated to reducing the stigma surrounding…
Lifting Brain Fog
Lifting Brain Fog https://www.damonapharma.com/wp-content/uploads/2019/09/brain-fog.png 1920 800 Etienne Sibille https://secure.gravatar.com/avatar/31fca8d52a9ddc2456d689e55abc91df?s=96&d=mm&r=gEffective treatments for cognitive dysfunction, such as declines in memory and other mental faculties often associated with depression or old age, may be within reach, according to Professor Etienne Sibille at the Centre for Addiction and Mental Health (CAMH) and the University of Toronto, Canada.
Insight into Novel Treatment for Cognitive Dysfunctions across Disorders
Insight into Novel Treatment for Cognitive Dysfunctions across Disorders https://www.damonapharma.com/wp-content/uploads/2020/04/article-image6.png 1920 800 Etienne Sibille https://secure.gravatar.com/avatar/31fca8d52a9ddc2456d689e55abc91df?s=96&d=mm&r=gCognitive dysfunctions, including impaired attention, learning, memory, and problem solving, occur in psychiatric diseases, such as depression, and are a hallmark of aging.
Des pilules pour la mémoire?
Des pilules pour la mémoire? https://www.damonapharma.com/wp-content/themes/crocal/images/empty/thumbnail.jpg 150 150 Etienne Sibille https://secure.gravatar.com/avatar/31fca8d52a9ddc2456d689e55abc91df?s=96&d=mm&r=gDes médicaments pourraient-ils permettre d’éviter les petites pertes de mémoire qui se multiplient fatalement, à mesure qu’on vieillit?
New therapeutic molecules developed at Toronto’s Centre for Addiction and Mental Health (CAMH) show promise in reversing the memory loss linked to depression and aging.
read moreDr. Sibille was interviewed by Ian Sample from The Guardian for his work on developing new therapeutics helping those with depression, schizophrenia and Alzheimer’s disease. Indeed, an experimental drug that bolsters ailing brain cells has raised hopes of a treatment for memory loss, poor decision making and other mental impairments that often strike in old…
read moreSenior Moment Stopper
Senior Moment Stopper https://www.damonapharma.com/wp-content/uploads/2020/05/folded-hands.png 1920 800 Etienne Sibille https://secure.gravatar.com/avatar/31fca8d52a9ddc2456d689e55abc91df?s=96&d=mm&r=gScientists hope the daily pill will clear “brain fog”, and roll back mental aging by decades
New therapeutic molecules developed at Toronto’s Centre for Addiction and Mental Health (CAMH) show promise in reversing the memory loss linked to depression and aging.
read more- 1
- 2